Filing Details
- Accession Number:
- 0001567619-22-001334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-19 18:34:31
- Reporting Period:
- 2022-01-14
- Accepted Time:
- 2022-01-19 18:34:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1247681 | Bryan V Lawlis | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-01-14 | 4,250 | $37.46 | 28,220 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-01-14 | 4,250 | $87.61 | 23,970 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2022-01-14 | 4,250 | $0.00 | 4,250 | $37.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,250 | 2012-11-08 | 2022-05-07 | No | 4 | M | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on July 29, 2021.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.